Insider Transactions in Q1 2024 at Moon Lake Immunotherapeutics (MLTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 29
2024
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,740
-0.16%
|
$260,700
$55.89 P/Share
|
|
Feb 28
2024
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,065
-1.84%
|
$3,083,575
$55.0 P/Share
|
|
Feb 28
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
28,090
-40.09%
|
$1,544,950
$55.0 P/Share
|
|
Feb 28
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
31,910
-1.08%
|
$1,755,050
$55.0 P/Share
|
|
Feb 27
2024
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
62,810
-2.02%
|
$3,454,550
$55.0 P/Share
|
|
Feb 27
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
29,431
-29.58%
|
$1,618,705
$55.0 P/Share
|
|
Feb 27
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
29,491
-0.99%
|
$1,622,005
$55.0 P/Share
|
|
Feb 21
2024
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,125
-0.04%
|
$61,875
$55.27 P/Share
|
|
Feb 21
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
569
-0.57%
|
$31,295
$55.3 P/Share
|
|
Feb 21
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
509
-0.02%
|
$27,995
$55.31 P/Share
|
|
Feb 20
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.09%
|
$570,000
$57.43 P/Share
|
|
Feb 20
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.33%
|
$570,000
$57.45 P/Share
|
|
Feb 20
2024
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.64%
|
$1,140,000
$57.44 P/Share
|
|
Feb 16
2024
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.64%
|
$1,200,000
$60.15 P/Share
|
|
Feb 16
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.33%
|
$600,000
$60.15 P/Share
|
|
Feb 16
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.33%
|
$600,000
$60.15 P/Share
|
|
Feb 15
2024
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.63%
|
$1,200,000
$60.18 P/Share
|
|
Feb 15
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.69%
|
$600,000
$60.16 P/Share
|
|
Feb 15
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.33%
|
$600,000
$60.17 P/Share
|
|
Feb 14
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.14%
|
$620,000
$62.43 P/Share
|
|
Feb 14
2024
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.33%
|
$620,000
$62.42 P/Share
|